1. Brachyury, a driver of tumor invasiveness and resistance to multiple therapies, is a novel immunotherapy target. (7th November 2013) Authors: Palena, Claudia; Fernando, Romaine I; Hamilton, Duane H; Huang, Bruce; Schlom, Jeffrey Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer. Issue 10 (October 2016) Authors: Hamilton, Duane H; Roselli, Mario; Ferroni, Patrizia; Costarelli, Leopoldo; Cavaliere, Francesco; Taffuri, Mariateresa; Palena, Claudia; Guadagni, Fiorella Journal: Endocrine-related cancer Issue: Volume 23:Issue 10(2016) Page Start: 783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High levels of expression of the transcription factor Brachyury induce resistance of human carcinoma cells to immune-mediated attack. (7th November 2013) Authors: Hamilton, Duane H; Huang, Bruce; Fernando, Romaine I; Tsang, Kwong-Yok; Palena, Claudia Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy. Issue 6 (25th June 2021) Authors: Reimann, Hannah; Nguyen, Andrew; Sanborn, J Zachary; Vaske, Charles J; Benz, Stephen C; Niazi, Kayvan; Rabizadeh, Shahrooz; Spilman, Patricia; Mackensen, Andreas; Ruebner, Matthias; Hein, Alexander; Beckmann, Matthias W; van der Meijden, Edith D; Bausenwein, Judith; Kretschmann, Sascha; Griffioen... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Influence of IL-8 on the epithelial–mesenchymal transition and the tumor microenvironment. (June 2012) Authors: Palena, Claudia; Hamilton, Duane H; Fernando, Romaine I Journal: Future oncology Issue: Volume 8:Number 6(2012) Page Start: 713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Interleukin-8 drives epithelial-mesenchymal transition of human carcinomas. (7th November 2013) Authors: Fernando, Romaine I; Hamilton, Duane H; Huang, Bruce; Palena, Claudia Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity. Issue 1 (17th March 2020) Authors: Horn, Lucas A; Riskin, Jeffrey; Hempel, Heidi A; Fousek, Kristen; Lind, Hanne; Hamilton, Duane H; McCampbell, Kristen K; Maeda, Dean Y; Zebala, John A; Su, Zhen; Schlom, Jeffrey; Palena, Claudia Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Upregulation of oncogenic MUC1 by the EMT transcription factor brachyury mediates immunotherapy-resistance in tumor cells. (4th November 2015) Authors: David, Justin M; Hamilton, Duane H; Dominguez, Charli L; Schlom, Jeffrey; Palena, Claudia Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗